The results in this study are consistent with an earlier study wherein dual treatment of neuroblastoma cells with the demethylating agent 5-Aza-2’-deoxycytidine and retinoic acid inhibited xenografted tumor growth while inducing EPAS1 expression along with several HIF2α target genes (6). Here, EPAS1 is linked to neoplasm.